We provide 1 form of Levetiracetam
Levetiracetam
102767-28-2
|
170.106
|
-0.344
Levetiracetam is an antiepileptic agent that binds to the synaptic vesicle protein SV2A. It is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older.
(2S)-(2-oxo-1-pyrrolidinyl)butanamide | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide | (S)-2-(2-oxopyrrolidin-1-yl)butanamide | keppra | levetiracetam
Levetiracetam is an antiepileptic agent that binds to the synaptic vesicle protein SV2A. It is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older.
(2S)-(2-oxo-1-pyrrolidinyl)butanamide | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | (S)-(-)-α-ethyl-2-oxo-1-pyrrolidineacetamide | (S)-2-(2-oxopyrrolidin-1-yl)butanamide | keppra | levetiracetam
$19/5 mg
(EBC)
1
We provide 4 compounds for Levetiracetam
Levetiracetam impurity C CRS
1,2-Dihydropyridin-2-one
2-Pyridone
142-08-5
95.037
-0.572
$41/5 mg
(EBC)
1
Levetiracetam impurity G CRS; Levetiracetam Related Compound B
(2S)-2-aminobutanamide hydrochloride
-
7682-20-4
138.056
-1.033
$19/5 mg
(EBC)
1
Levetiracetam impurity A CRS
2-(2-oxopyrrolidin-1-yl)butanoic acid
-
67118-31-4
171.09
0.478
$80/5 mg
(EBC)
1
Levetiracetam impurity D CRS
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
levetiracetam
103765-01-1
170.106
-0.344
$480/5 mg
(EBC)
1